U.S. News

2244 readers

3 users here now

News about and pertaining to the United States and its people.

Please read what's functionally the mission statement before posting for the first time. We have a narrower definition of news than you might be accustomed to.

Guidelines for submissions:

Post the original source of information as the link.
If there is a paywall, provide an archive link in the body.
Post using the original headline; edits for clarity (as in providing crucial info a clickbait hed omits) are fine.
Social media is not a news source.

For World News, see the News community.

This community's icon was made by Aaron Schneider, under the CC-BY-NC-SA 4.0 license.

founded 1 year ago

MODERATORS

alyaza

rs5th

Powderhorn

'The whole thing's a mess': Anger and panic as ADHD drug shortages drag on (www.nbcnews.com)

submitted 1 year ago by alyaza to c/usnews

9 comments fedilink hide all child comments

you are viewing a single comment's thread
view the rest of the comments

[–] autotldr@lemmings.world 3 points 1 year ago

🤖 I'm a bot that provides automatic summaries for articles:

Click here to see the summary

Experts doubt the supply of the attention-deficit/hyperactivity disorder medication Adderall or other ADHD drugs will increase any time soon, with shortages potentially lasting through the end of the year.

Dr. Leila Javidi, a primary care doctor in Gahanna, Ohio has been fielding several hundred calls and messages each month from patients who say finding a stocked pharmacy becomes a time-consuming, frustrating quest.

The shortage began with Adderall last fall, but has since had a domino effect, with long- and short-acting versions of methylphenidate (Ritalin and Concerta), as well as Focalin, Vyvanse, and numerous generic equivalents of these drugs now in short supply, too.

Millions of children and adults in the United States are prescribed ADHD medications, which work by increasing dopamine levels in the brain to improve focus.

William Newman, an attorney who represents Ascent Pharmaceuticals with his partner Nick Oberheiden, said in an email that the company is still waiting on this year’s quota it requested from the DEA in 2022.

Even if telehealth changes do lower demand, Wiznitzer said, he wouldn’t be surprised if the ADHD medication shortage continues well into the fall, and potentially through the end of the year.

Saved 88% of original text.